Dual Loss of PI3Kα and PI3Kγ Leads to a Paradoxical Increase in AKT Activation and Physiological Hypertrophy

被引：0
|
作者：
Guo, Danny [1 ]
Basu, Ratnadeep [1 ]
Chow, Fung L. [1 ]
Wang, Xiuhua [1 ]
Kassiri, Zamaneh [1 ]
Oudit, Gavin Y. [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
来源：
JOURNAL OF CARDIAC FAILURE | 2010年 / 16卷 / 08期
关键词：
D O I：
10.1016/j.cardfail.2010.06.121
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
107
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [21] Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ
    Uehara, Mayuko
    McGrath, Martina M.
    Ohori, Shunsuke
    Solhjou, Zhabiz
    Banouni, Naima
    Routray, Sujit
    Evans, Catherine
    DiNitto, Jonathan P.
    Elkhal, Abdallah
    Turka, Laurence A.
    Strom, Terry B.
    Tullius, Stefan G.
    Winkler, David G.
    Azzi, Jamil
    Abdi, Reza
    NATURE COMMUNICATIONS, 2017, 8
  • [22] Targeting aberrant PI3K/Akt activation by the dual PI3K/mTOR inhibitor PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma
    Opel, D.
    Naumann, I
    Schneider, M.
    Bertele, D.
    Debatin, K-M
    Fulda, S.
    ONKOLOGIE, 2011, 34 : 49 - 49
  • [23] NFκB activation participates in PI3K/Akt pathway induced cardiac hypertrophy
    Li, YH
    Ha, TZ
    Zhao, AQ
    Gao, X
    Kelley, J
    Williams, DL
    Browder, IW
    Li, CF
    FASEB JOURNAL, 2005, 19 (05): : A1199 - A1200
  • [24] PI3K and MAPK Activation During Eccentric Cardiac Hypertrophy
    Zhao, Aiqiu
    Alvin, Zikiar
    Cousins, Valerie
    Haddad, Georges E.
    FASEB JOURNAL, 2010, 24
  • [25] Src leads to a novel mechanism of resistance to PI3K inhibitors through regulation of PI3K/p85 activation
    Kim, Gui Chul
    Nam, Hae Yun
    Lee, Hyang Ju
    Kim, Min Kyung
    Lee, Geun Hee
    Han, Myung Woul
    Kim, Seong Who
    Kim, Sang Yoon
    CANCER RESEARCH, 2017, 77
  • [26] Developing predictive biomarkers of PI3K/AKT pathway activation
    Savage, Heidi M.
    Mullappally, Berny
    Mohan, Sankar
    Pandita, Ajay
    Shames, David
    Lackner, Mark
    Punnoose, Elizabeth
    CANCER RESEARCH, 2010, 70
  • [27] Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual Inhibitors
    Jia, Hong
    Dai, Guangxiu
    Su, Weiguo
    Xiao, Kun
    Weng, Jianyang
    Zhang, Zhulin
    Wang, Qing
    Yuan, Tianhai
    Shi, Fuying
    Zhang, Zheng
    Chen, Wei
    Sai, Yang
    Wang, Jian
    Li, Xiong
    Cai, Yu
    Yu, Jun
    Ren, Ping
    Venable, Jennifer
    Rao, Tadimeti
    Edwards, James P.
    Bembenek, Scott D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (10) : 4936 - 4948
  • [28] Dual targeting of pi3k/mTOR
    Fokas, E.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S43 - S43
  • [29] Role of SMO in the Activation of PI3K/AKT Signaling in DLBCL
    Vaghefi, Amineh
    Agarwal, Nitin K.
    Kunkalla, Kranthi
    Kim, Chae Hwa
    Tjendra, Youley
    Landgraf, Ralf
    Vega, Francisco
    MODERN PATHOLOGY, 2017, 30 : 382A - 382A
  • [30] Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma
    Hafner, Christian
    Houben, Roland
    Baeurle, Anne
    Ritter, Cathrin
    Schrama, David
    Landthaler, Michael
    Becker, Juergen C.
    PLOS ONE, 2012, 7 (02):
12345